Matches in Wikidata for { <http://www.wikidata.org/entity/Q59327301> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q59327301 description "article scientifique publié en 2018" @default.
- Q59327301 description "im November 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59327301 description "wetenschappelijk artikel" @default.
- Q59327301 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q59327301 name "358. Comparison of Voriconazole (VORI), Isavuconazole (ISAV), and Posaconazole (POSA) in the Initial Treatment of Patients With Invasive Aspergillosis (IA)" @default.
- Q59327301 name "358. Comparison of Voriconazole (VORI), Isavuconazole (ISAV), and Posaconazole (POSA) in the Initial Treatment of Patients With Invasive Aspergillosis (IA)" @default.
- Q59327301 type Item @default.
- Q59327301 label "358. Comparison of Voriconazole (VORI), Isavuconazole (ISAV), and Posaconazole (POSA) in the Initial Treatment of Patients With Invasive Aspergillosis (IA)" @default.
- Q59327301 label "358. Comparison of Voriconazole (VORI), Isavuconazole (ISAV), and Posaconazole (POSA) in the Initial Treatment of Patients With Invasive Aspergillosis (IA)" @default.
- Q59327301 prefLabel "358. Comparison of Voriconazole (VORI), Isavuconazole (ISAV), and Posaconazole (POSA) in the Initial Treatment of Patients With Invasive Aspergillosis (IA)" @default.
- Q59327301 prefLabel "358. Comparison of Voriconazole (VORI), Isavuconazole (ISAV), and Posaconazole (POSA) in the Initial Treatment of Patients With Invasive Aspergillosis (IA)" @default.
- Q59327301 P1433 Q59327301-80A0331B-D5E2-4AAC-B64D-A1D894AA3DAD @default.
- Q59327301 P1476 Q59327301-A201DE31-CCC9-444A-A3B4-6A4A2FB31AC7 @default.
- Q59327301 P2093 Q59327301-0DF45B94-6390-4B06-BED7-567F029E37E1 @default.
- Q59327301 P2093 Q59327301-B5B889C3-327B-459E-A83F-A35E7D1C5611 @default.
- Q59327301 P2093 Q59327301-CC1E9E9C-C7D9-47CB-BDF3-3B64102AE725 @default.
- Q59327301 P2093 Q59327301-E5FC7623-C75E-490C-B719-74AE70E5D50C @default.
- Q59327301 P275 Q59327301-f3cd7ad7-968c-40cf-9be6-77c3518847ae @default.
- Q59327301 P304 Q59327301-855D57A0-870B-43DD-941C-ED448318B448 @default.
- Q59327301 P31 Q59327301-E8071A75-C40E-4C42-8EFC-351A2A332768 @default.
- Q59327301 P356 Q59327301-448D5641-D871-4112-AA7D-78560592BA4D @default.
- Q59327301 P433 Q59327301-BE742EFD-0BF4-4823-BE44-5E9C59DFB15B @default.
- Q59327301 P478 Q59327301-6BBB39DF-27B4-4716-A512-5C242BF34C5C @default.
- Q59327301 P50 Q59327301-8862BCFF-9DB6-401A-B08A-27C9859000CE @default.
- Q59327301 P50 Q59327301-C8169CD8-2772-4300-8D70-4EEA26163D54 @default.
- Q59327301 P577 Q59327301-D784953B-4F6B-4A1D-8D2E-D4EA17DE973A @default.
- Q59327301 P6216 Q59327301-44c77e46-0671-4ff8-b82c-c586695e0c91 @default.
- Q59327301 P8608 Q59327301-00B05011-722F-40E7-B2A9-3C01D1C8A52D @default.
- Q59327301 P921 Q59327301-7E7F91F3-E997-4F11-9985-71D2A41B8226 @default.
- Q59327301 P921 Q59327301-C9441DA4-6592-46D9-85E5-20B7EF820F2E @default.
- Q59327301 P932 Q59327301-528A6F6D-5410-47E3-842E-E1AB4D755D31 @default.
- Q59327301 P356 OFY210.369 @default.
- Q59327301 P1433 Q27725953 @default.
- Q59327301 P1476 "358. Comparison of Voriconazole (VORI), Isavuconazole (ISAV), and Posaconazole (POSA) in the Initial Treatment of Patients With Invasive Aspergillosis (IA)" @default.
- Q59327301 P2093 "Esther Arbona-Haddad" @default.
- Q59327301 P2093 "José Luis Orejas" @default.
- Q59327301 P2093 "Matthew P Cheng" @default.
- Q59327301 P2093 "Sarah Hammond" @default.
- Q59327301 P275 Q24082749 @default.
- Q59327301 P304 "S140-S141" @default.
- Q59327301 P31 Q13442814 @default.
- Q59327301 P356 "10.1093/OFID/OFY210.369" @default.
- Q59327301 P433 "Suppl 1" @default.
- Q59327301 P478 "5" @default.
- Q59327301 P50 Q43126104 @default.
- Q59327301 P50 Q48052401 @default.
- Q59327301 P577 "2018-11-01T00:00:00Z" @default.
- Q59327301 P6216 Q50423863 @default.
- Q59327301 P8608 "release_7tvy3hpwrbdnhmwrzde5ywtx5y" @default.
- Q59327301 P921 Q3625278 @default.
- Q59327301 P921 Q412236 @default.
- Q59327301 P932 "6255647" @default.